Initial treatment of renal bone disease and cinacalcet ...
1.6K
Description

Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism. Calcium-containing phosphate binders also improve hypocalcaemia. 


Calcitriol improves hypocalcaemia and hyperparathyroidism.


Addition of cinacalcet to the first-line treatments inhibits PTH release. This decreases secondary hyperparathyroidism which reduces bone turnover and associated electrolyte disturbances.


#Pharmacology #Pathophysiology #Secondary #Hyperparathyroidism #Sensipar #Cinacalcet #Calcitriol
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
0 Comments

Related content